Lexaria to Begin New Human Clinical Study in GLP-1

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. SPY
3. META
4. ABBV
5. FDX
6. IBM
7. NKE
8. MU
9. PFE
10. AWK

Go back to Lexaria to Begin New Human Clinical Study in GLP-1
(NASDAQ: LEXX) Delayed: 0.57 -0.01 (1.72%)
Previous Close $0.58    52 Week High $ 
Open $0.60    52 Week Low $ 
Day High $0.61    P/E N/A 
Day Low $0.56    EPS $ 
Volume 49,361